Search
    ×

    Investors Overview

    Fundamentals - Snapshot

    Revenue & Earnings

    Revenue (FY) $17,117.00
    EBIT (Mil) (FY) $2,610.00
    EBIT (Mil) (MRQ) $526.00
    EBIT (Mil) (TTM) $3,492.00
    EBITDA (Mil) (FY) $4,764.00
    EBITDA (Mil) (MRQ) $1,094.00
    EBITDA (Mil) (TTM) $5,726.00
    Net Income Excluding Extraordinary Items (Mil) (FY) $874.00
    Net Income Including Extraordinary Items (Mil) (FY) $874.00
    Diluted EPS Excluding Extraordinary Items (FY) $2.72
    Diluted EPS Including Extraordinary Items (FY) $2.72

    Dividends

    Yield (%) 1.32
    Dividend Record Date 9/9/21
    Dividend Rate 3.32%

    Ratios

    Price to Revenue (TTM) $3.63
    Price to Revenue (MRQ) $3.68
    Price to Revenue (FY) $4.22
    Price To Cash Flow (TTM) $17.62
    Price to Cash Flow (MRQ) $16.82
    Price to Cash Flow (FY) $24.72
    Price to Book (MRQ) $2.99
    Price to Book (FY) $3.07
    Total Debt to Equity (MRQ) (%) 73.47%
    Total Debt to Equity (FY) (%) 75.45%
    Current Ratio (MRQ) $1.23
    Current Ratio (FY) $1.54

    Ratios

    Price to Revenue (TTM) $3.63
    Price to Revenue (MRQ) $3.68
    Price to Revenue (FY) $4.22
    Price To Cash Flow (TTM) $17.62
    Price to Cash Flow (MRQ) $16.82
    Price to Cash Flow (FY) $24.72
    Price to Book (MRQ) $2.99
    Price to Book (FY) $3.07
    Total Debt to Equity (MRQ) (%) 73.47%
    Total Debt to Equity (FY) (%) 75.45%
    Current Ratio (MRQ) $1.23
    Current Ratio (FY) $1.54

    Growth

    5-Year Annual Dividend Growth Rate (%) 5.66%
    5-Year Annual Revenue Growth Rate (%) 10.73%

    FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

    Copyright Refinitiv

    Investor Highlights

    Placeholder

    Meet Jonathan

    Moments after crossing the finish line of a half marathon, Jonathan went into cardiac arrest due to a congenital defect in his artery.
    Placeholder

    Drone Delivery Capabilities

    See how BD and WeRobotics worked to advance drones for healthcare in the Peruvian Amazon
    Placeholder

    AMR Leadership

    BD solutions to combat antimicrobial resistance